Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Medpace Holdings, Inc. (MEDP : NSDQ)
 
 • Company Description   
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

Number of Employees: 4,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $133.32 Daily Weekly Monthly
20 Day Moving Average: 383,695 shares
Shares Outstanding: 33.65 (millions)
Market Capitalization: $4,485.84 (millions)
Beta: 1.53
52 Week High: $231.00
52 Week Low: $126.95
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.54% 6.50%
12 Week -12.23% -4.11%
Year To Date -38.74% -25.93%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5375 MEDPACE WAY
-
CINCINNATI,OH 45227
USA		 ph: 513-579-9911
fax: 513-579-0444		 investor@medpace.com http://www.medpace.com
 
 • General Corporate Information   
Officers
August J. Troendle - Chief Executive Officer and Chairman of the Board
Kevin M. Brady - Chief Financial Officer
Brian T. Carley - Director
Robert O. Kraft - Director
Fred B. Davenport Jr. - Director

Peer Information
Medpace Holdings, Inc. (CHCR)
Medpace Holdings, Inc. (ESRX)
Medpace Holdings, Inc. (MYDP)
Medpace Holdings, Inc. (GBCS)
Medpace Holdings, Inc. (LAXAF)
Medpace Holdings, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 58506Q109
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/25/22
Share - Related Items
Shares Outstanding: 33.65
Most Recent Split Date: (:1)
Beta: 1.53
Market Capitalization: $4,485.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.33 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $5.87 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/25/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 22.73
Trailing 12 Months: 24.87
PEG Ratio: -
Price Ratios
Price/Book: 7.41
Price/Cash Flow: 23.68
Price / Sales: 3.70
EPS Growth
vs. Year Ago Period: 44.44%
vs. Previous Quarter: 28.03%
Sales Growth
vs. Year Ago Period: 27.30%
vs. Previous Quarter: 7.26%
ROE
03/31/22 - 24.17
12/31/21 - 20.55
09/30/21 - 21.71
ROA
03/31/22 - 13.21
12/31/21 - 11.89
09/30/21 - 12.59
Current Ratio
03/31/22 - 0.61
12/31/21 - 1.24
09/30/21 - 1.24
Quick Ratio
03/31/22 - 0.61
12/31/21 - 1.24
09/30/21 - 1.24
Operating Margin
03/31/22 - 16.47
12/31/21 - 16.02
09/30/21 - 16.95
Net Margin
03/31/22 - 16.47
12/31/21 - 15.92
09/30/21 - 16.71
Pre-Tax Margin
03/31/22 - 18.02
12/31/21 - 17.67
09/30/21 - 18.35
Book Value
03/31/22 - 17.98
12/31/21 - 26.51
09/30/21 - 24.99
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©